• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    89.09 Up 1.83(2.10%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 889,895   749,284   548,485  
    Cost of Revenue152,008  122,267  88,391  
    Gross Profit 737,887   627,017   460,094  
    Operating Expenses
    Research Development634,806  461,543  354,780  
    Selling General and Administrative402,271  302,156  235,356  
    Non Recurring198,700   -  939  
    Others(17,690)23,709  25,026  
    Total Operating Expenses1,218,087   -  616,101  
    Operating Income or Loss (110,702) (92,891) (156,007)
    Income from Continuing Operations
    Total Other Income/Expenses Net364,537  73,042  (8,900)
    Earnings Before Interest And Taxes(116,480)(88,226)(166,056)
    Interest Expense38,244  36,642  10,447  
    Income Before Tax(154,724)(124,868)(176,503)
    Income Tax Expense17,075  9,101  (150)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(172,616)(134,846)(177,502)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (171,799) (133,969) (176,353)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (171,799) (133,969) (176,353)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.